Cannabis

Stroke and cannabis use in patients with no cardiovascular risk factors: a systematic review of case reports.

INTRODUCTION: Cannabis and its synthetic analogues are currently the most widely consumed illicit substances worldwide. Multiple alterations have been linked to its use, including cerebrovascular disease (CVD) or stroke, whose association with the substance has been based mainly on the hypothesis of transient vasoconstriction, which… Read More »Stroke and cannabis use in patients with no cardiovascular risk factors: a systematic review of case reports.

Medicinal Cannabis – Government Management

Access to medicinal Cannabis Products (TGA) https://www.tga.gov.au/access-medicinal-cannabis-products Access to medicinal cannabis products: steps to using access … https://www.tga.gov.au/access-medicinal-cannabis-products-steps-using-access-schemes https://www.tga.gov.au/medicinal-cannabis-products-overview-regulation https://www.tga.gov.au/form/medicinal-cannabis-products

Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder

Highlights Patients with depression frequently used marijuana and nearly half met the AUD criteria. Fewer patients with AUD were using marijuana at baseline compared to patients without AUD. Patients with AUD using marijuana increased over 6 months compared to those without AUD. Patients with AUD… Read More »Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder

Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].

Abstract BACKGROUND:  medical cannabis refers to the use of cannabis or cannabinoids as medical therapy to treat disease or alleviate symptoms. In the United States, 23 states and Washington DC (May 2015) have introduced laws to permit the medical use of cannabis. Within the European… Read More »Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].